TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 47 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12 | -45.5% | 18,077 | -33.9% | 0.00% | -50.0% |
| Q1 2023 | $22 | -94.7% | 27,338 | -85.1% | 0.00% | -96.2% |
| Q4 2022 | $416 | -99.9% | 183,857 | -22.1% | 0.05% | -13.3% |
| Q3 2022 | $456,000 | -34.3% | 236,120 | +26.6% | 0.06% | -42.3% |
| Q2 2022 | $694,000 | -9.2% | 186,480 | +59.2% | 0.10% | +1.0% |
| Q1 2022 | $764,000 | +60.5% | 117,109 | +186.4% | 0.10% | +71.7% |
| Q4 2021 | $476,000 | +6.2% | 40,885 | +104.4% | 0.06% | -20.0% |
| Q3 2020 | $448,000 | – | 20,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Investment Advisors, LLC | 10,000 | $17,700 | 0.00% |